This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2003-2004.
Company Filing History:
Years Active: 2003-2004
Title: Andrea Koenig: Innovator in Medical Research
Introduction
Andrea Koenig is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of medical research, particularly in the area of inhibiting specific cellular interactions that can lead to various pathologies. With a total of 2 patents to her name, her work has the potential to impact treatment methodologies significantly.
Latest Patents
Koenig's latest patents focus on the inhibition of L-selectin and P-selectin mediated binding using heparin. The first patent outlines methods for inhibiting these interactions in a subject by administering heparin in a manner that avoids substantial anticoagulant activity or undesirable bleeding. Additionally, it provides treatment methods for subjects with pathologies characterized by abnormal L-selectin or P-selectin mediated binding, specifying a concentration of less than about 0.2-0.4 units of heparin per ml of plasma.
Career Highlights
Andrea Koenig is affiliated with the University of California, where she conducts her research and develops her innovative ideas. Her work has garnered attention for its potential applications in treating various medical conditions.
Collaborations
Koenig collaborates with Ajit Varki, a fellow researcher, to further explore the implications of her inventions in the medical field.
Conclusion
Andrea Koenig's contributions to medical research through her patents demonstrate her commitment to advancing healthcare solutions. Her innovative approaches to inhibiting cellular interactions could lead to significant improvements in treatment options for patients.